Genmab — April 2017
-
Humax-AXL-ADC forsøget kører som mono behandling https://clinicaltrials.gov/ct2/show/NCT02988817?term=humax+axl&rank=1 Det følger den kendte introduktion af nye stoffer i klinikken, hvor der først skal betemmes max tolereret dosis ift bivirkninger
-
-
Efter kursfaldet kan vi nu konstantere at gulvet i 1.240 er stærkt og aktien flot holder sig i den langsigtede stigende trend.
-
Multiple Myeloma Survival in India by Priya Menon and Gary Petersen
India has 1.24 billion people, or a population that is nearly 4 times greater than the USA. The USA has nearly 22,000 newly diagnosed patients with multiple myeloma, and the best information I...
Multiple Myeloma - Survival Rate Statistics by Hospital (myelomasurvival.com)
-
Ved ikke om denne har været nævnt - Syros og Dara. http://finance.yahoo.com/news/syros-presents-data-aacr-further-120100400.html?soc_src=social-sh&soc_trk=tw https://clinicaltrials.gov/ct2/show/NCT02807558?term=syros&rank=1
-
-
1.278.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind